The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study
SGLT2 inhibitors demonstrated a lower prevalence of anemia and a lower risk of hospitalizations attributed to anemia when compared to treatment with DPP4 inhibitors in patients with diabetes.
Authors
- Amir Schechter (ORCID: https://orcid.org/0000-0001-8539-8246)
- Benaya Rozen Zvi (ORCID: https://orcid.org/0000-0002-8303-7794)
- Shiri Kushnir (ORCID: https://orcid.org/0000-0003-2359-5249)
- Timna Agur (ORCID: https://orcid.org/0000-0001-8263-0900)
- Anat Gafter Gvili
- Shira Goldman (ORCID: https://orcid.org/0000-0001-7011-5872)
- Alon Grossman (ORCID: https://orcid.org/0000-0002-6969-4296)
- Kim Ben Tikva Kagan (ORCID: https://orcid.org/0000-0002-7966-1252)
- Dana Bielopolski (ORCID: https://orcid.org/0000-0001-9476-0032)
- Shira Buchrits (ORCID: https://orcid.org/0000-0002-1034-8583)
- Adi Turjeman (ORCID: https://orcid.org/0000-0003-2200-9922)
- Tali Steinmetz (ORCID: https://orcid.org/0000-0002-5377-9156)
Institutions
- Tel Aviv University (IL)
- Technion – Israel Institute of Technology (IL)
- Hebrew University of Jerusalem (IL)
- Rabin Medical Center (IL)
- Rappaport Family Institute for Research in the Medical Sciences (IL)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2025-03-22
- DOI
- https://doi.org/10.1210/clinem/dgaf184
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.88